MASH (formerly known as NASH) Patient Stories Needed
- October 16, 2025
Unlocking the Future: Sleep Disorder Biomarkers Predict Parkinson’s and Dementia
Datroway Shows Survival Benefit in Late-Stage Trial for Triple-Negative Breast Cancer
Investigational Cell Therapy Bemdaneprocel Shows Sustained Safety and Promising Motor Improvements at 36 Months in Parkinson’s Disease Trial
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
October is Prenatal-onset GBS Disease Recognition Month. Did you know GBS can impact babies before birth? Learn the signs, ask about testing and prevention, and help protect the tiniest lives. #GBSAwareness #prenatalhealth #healthypregnancy #PatientWorthy
Unlocking the Future: Sleep Disorder Biomarkers Predict Parkinson’s and Dementia bit.ly/3IZpfSu Read now at PatientWorthy.com
#PatientWorthy #Parkinson'sDisease
💙 You’re not imagining it. You’re not alone. And you’re doing your best.
If you're interested in learning more or joining the conversation this week, visit patientworthy.com for the latest information.
#ParkinsonsDisease #CaregiverSupport #PatientWorthy#ParkinsonsPsychosis
